CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: New predictive factors of tumor progression in cutaneous malignant melanoma

Clinical and Experimental Metastasis

Volumn 29, Issue 6, 2012, Pages 625-637

  Monteagudo, Carlos ^a,b   Ramos, David ^a   Pellín Carcelén, Ana ^a   Gil, Rosario ^a   Callaghan, Robert C ^a   Martín, José M ^b   Alonso, Vicent ^b   Murgui, Amelia ^a   Navarro, Lara ^a   Calabuig, Silvia ^b   López Guerrero, José Antonio ^c   Jordá, Esperanza ^b   Pellín, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

CCL27; CCR10; Chemokine receptors; Chemokines; CXCL12; CXCR4; Melanoma; Metastasis; Prognosis

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CXCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ADULT; ANTIBODY LABELING; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER PATIENT; CELL TYPE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULE; PREDICTIVE VALUE; PRIMARY TUMOR; PROGNOSIS; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR GROWTH; TUMOR VOLUME;

AGED; CHEMOKINE CCL27; CHEMOKINE CXCL12; CHEMOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RECEPTORS, CCR10; RECEPTORS, CXCR4; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 84863717256     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9476-2     Document Type: Article

References (61)

1. Kuphal S, Bosserhoff A (2009) Recent progress in understanding the pathology of malignant melanoma. J Pathol 219:400-409
2. Beddingfield FC III (2003) The melanoma epidemic: Res Ipsa Loquitur. Oncologist 8:459-465
3. Thompson JF, Scolier RA, Kefford RF (2005) Cutaneous melanoma. Lancet 365:687-701
4. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA (2009) Increasing burden of melanoma in the United States. J Invest Dermatol 129:1666-1674
5. Burton RC, Armstrong BK (1994) Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res 4:107-113
6. Lambert L (2002) Epidemic of malignant melanoma. True increase or better detection? JAMA 287:2201
7. Gimotty PA, Guerri D, Ming ME et al (2004) The primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 22:3668-3676
8. Balch CM, Gershenwald JE, Soong SJ et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-6206
9. Kalady MF, White RR, Johnson JL, Tyler DS, Seigler HF (2003) Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg 238:528-535
10. King R, Googe PB, Mihm MC Jr (2000) Thin melanomas. Clin Lab Med 20:713-729
11. Müller A, Homey B, Soto H et al (2001) Involvement of che-mokine receptors in breast cancer metastasis. Nature 410:50-56
12. Zlotnik A (2004) Chemokines in neoplastic progression. Semin Cancer Biol 14:181-185
13. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550
14. Kulbe H, Levinson NR, Balkwill F, Wilson JL (2004) The che-mokine network in cancer-much more than directing cell movement. Int J Dev Biol 48:489-496
15. Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16:133-144
16. Thelen M, Stein JV (2008) How chemokines invite leukocytes to dance. Nat Immunol 9:953-959
17. Sun YX, Wang J, Shelburne CE et al (2003) Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89:462-473
18. Salmaggi A, Maderna E, Calatozzolo C et al (2009) CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer Biol Ther 8:1608-1614
19. Liang Z, Wu T, Lou H et al (2004) Inhibition of breast cancer metastasis by selective polypeptide against CXCR4. Cancer Res 64:4302-4308
20. Takenaga M, Tamamura H, Hiramatsu K et al (2004) A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma. Biochem Biophys Res Commun 320:226-232
21. Kim SY, Lee CH, Midura BV et al (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25: 201-211
22. Bartolomé RA, Ferreiro S, Miquilena-Colina ME et al (2009) The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol 174:602-612
23. Robledo MM, Bartolomé RA, Longo N et al (2001) Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 276:45098-45105
24. Scala S, Ottaiano A, Ascierto PA et al (2005) Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 11:1835-1841
25. Scala S, Giuliano P, Ascierto PA et al (2006) Human melanoma metastases express functional CXCR4. Clin Cancer Res 12: 2427-2433
26. Longo-Imedio MI, Longo N, Treviño I, Lázaro P, Sanchez-Mateos P (2005) Clinical significance of CXCR3 and CXCR4 expression in primary melanoma. Int J Cancer 117:861-865
27. Schioppa T, Uranchimeg B, Saccani A et al (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198: 1391-1402
28. Schutyser E, Su Y, Yu Y et al (2007) Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw 18:59-70
29. Brandt S, Dambacher J, Beigel F et al (2005) CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310:117-130
30. Petit I, Szyper-Kravitz M, Nagler A et al (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687-694
31. Hasegawa H, Nomura T, Kohno M et al (2000) Increased che-mokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T cell leukemia cells. Blood 95: 30-38
32. Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93: 1638-1643
33. Forster R, Ohl L, Henning G (2001) Lessons learned from lymphocytes: CC chemokine receptor-7 involved in lymphogenic metastasis of melanoma. J Natl Cancer Inst 93:1588-1589
34. Mashino K, Sadanaga N, Yamaguchi H et al (2002) Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62:2937-2941
35. Takanami I (2003) Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105:186-189
36. Ding Y, Shimada Y, Maeda M et al (2003) Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9:3406-3407
37. Carrière V, Colisson R, Jiguet-Jiglaire C et al (2005) Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node. Cancer Res 65: 11639-11648
38. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS (2004) CCL21 chemokine regulates receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10:2351-2358
39. Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA (2007) Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and auto-crine CCR7 signaling. Cancer Cell 11:526-538
40. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328:749-752
41. Simonetti O, Goteri G, Lucarini G et al (2006) Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur J Cancer 42:1181-1187
42. Pivarcsi A, Müller A, Hippe A et al (2007) Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci USA 104:19055-19060
43. Jaeger J, Koczan D, Thiesen HJ et al (2007) Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res 13:806-815
44. Goidin D, Mamessier A, Staquet MJ, Schmitt D, Berthier-Verg-nes O (2001) Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and b-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Bio-chem 295:17-21
45. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt method. Methods 25:402-408
46. Vicari AP, Caux C (2002) Chemokines in cancer. Cytokine Growth Factor Rev 13:143-154
47. Richmond A, Yang J, Su Y (2009) The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res 22:175-186
48. Thellin O, Zorzi W, Lakaye B et al (1999) Housekeeping genes as internal standards: use and limits. J Biotechnol 75:291-295
49. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A (2004) Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37:112-119
50. Bustin SA, Nolan T (2004) Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 15:155-166
51. Gilsbach R, Kouta M, Bonisch H, Bruss M (2006) Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 40:173-177
52. Giricz O, Lauer-Fields JL, Fields GB (2008) The normalization of gene expression data in melanoma: investigating the use of glyceraldehyde 3-phosphate dehydrogenase and 18S ribosomal RNA as internal reference genes for quantitative real-time PCR. Anal Biochem 380:137-139
53. Minner F, Poumay Y (2009) Candidate housekeeping genes require evaluation before their selection for studies of human epidermal keratinocytes. J Invest Dermatol 129:770-773
54. Bär M, Bär D, Lehmann B (2009) Selection and validation of candidate housekeeping genes for studies of human keratino-cytes-review and recommendations. J Invest Dermatol 129: 535-537
55. Peled A, Petit I, Kollet O et al (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-848
56. Murakami T, Maki W, Cardones AR et al (2002) Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62: 7328-7334
57. Guleng B, Tateishi K, Ohta M et al (2005) Blockade of the stromal cell-derived factor/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65:5864-5871
58. Orimo A, Gupta PB, Sgroi DC et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348
59. Bartolomé RA, Gálvez BG, Longo N, Baleux F, Van Muijen GN, Sánchez-Mateos P (2004) Stromal cell-derived factor-1a promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metallopro-teinase and Rho GTPase activities. Cancer Res 64:2534-2543
60. Kochetkova M, Kumar S, McColl SR (2009) Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ 16:664-673
61. Murakami T, Cardones AR, Finkelstein SE et al (2003) Immune evasion by murine melanoma mediated through chemokine receptor-10. J Exp Med 198:1337-7334